slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,834
Current window 295,561-295,590
Pages 10,128
Rows per page 30
Component
295,561-295,590 of 303,834
07
The slide highlights the lack of analyst coverage and low float (34%) resulting in low trading volume for Taro Pharma.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · Market Size1 hit
08
The slide uses a mix of historical (A) and estimated (E) data, with specific H1 comparisons.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · Market Size1 hit
09
The slide uses a combination of annual historical/forecast data and half-year comparisons to explain cost structure changes.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · Financials1 hit
10
Includes a detailed income statement table with Q1, Q2, H1 2012 actuals and 2012 estimates.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · Financials1 hit
11
10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · Financials1 hit
12
Includes two bar charts showing historical/projected growth and a median benchmark line.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · FinancialsLoop · Pattern Hunter1 hit
13
Taro is highlighted in blue in each chart, while peers are in grey. Medians are indicated by red dashed lines.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · FinancialsLoop · Pattern Hunter1 hit
14
Includes specific footnotes regarding adjustments for peer data (e.g., Actavis, Paddock, Flomax).10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · FinancialsLoop · Pattern Hunter1 hit
15
10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · ValuationLoop · Golden Circle1 hit
16
Includes specific financial benchmarks like P/E ratios and valuation ranges relative to Sun Pharma's offer price.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · ValuationLoop · Golden Circle1 hit
17
Includes data on price bumps, offer premiums, and transaction duration.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · ValuationLoop · Golden Circle1 hit
18
Includes sensitivity tables for WACC vs Terminal EBITDA Multiple, WACC vs Implied Perpetuity Growth Rate, and WACC vs Terminal Value as a % of Enterprise Value.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · ValuationLoop · Golden Circle1 hit
19
The chart highlights a period of multiple uplift attributed to stock price appreciation ahead of product pricing increases.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · ValuationLoop · Golden Circle1 hit
20
Includes median lines for the full peer set and a sub-segment of sub-$5bn market cap peers.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · ValuationLoop · Golden Circle1 hit
21
10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank 1 hit
22
Depreciation and amortization allocated 75%:25% between COGS and SG&A per Taro management.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Loop · Cost Of Inaction1 hit
23
Includes mean and median calculations for the peer group and a sub-segment of peers under $5bn market cap.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Loop · Cost Of Inaction1 hit
24
Includes a legend for healthcare deals and footnotes regarding data sources and methodology.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Loop · Cost Of Inaction1 hit
25
Includes a legend for healthcare deals and a note about exclusions.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Loop · Cost Of Inaction1 hit
26
Market data as of August 10, 2012. Cost of debt estimated based on current B rated high yield index.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank 1 hit
27
The slide combines a dense legal disclaimer block with a paragraph describing corporate sustainability efforts.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank 1 hit
01
This appears to be the first page of a 48-page document/essay.11 laws of showrunning mean version · 11-laws-of-showrunning-mean-version
Deck Investor relations Beat · Attention1 hit
07
The slide is a text-heavy page from a larger document, likely a guide or manifesto on showrunning.11 laws of showrunning mean version · 11-laws-of-showrunning-mean-version
Deck Investor relations Beat · Need1 hit
11
The text is written in a conversational, slightly provocative tone, typical of a manifesto or advice-based presentation.11 laws of showrunning mean version · 11-laws-of-showrunning-mean-version
Deck Investor relations Beat · SatisfactionLoop · Aha Moment1 hit
12
The text is a continuation of a larger document, focusing on leadership philosophy in television production.11 laws of showrunning mean version · 11-laws-of-showrunning-mean-version
Deck Investor relations Beat · Satisfaction1 hit
15
The text is a continuation of a series of 'laws' for showrunners, focusing on management and creative leadership.11 laws of showrunning mean version · 11-laws-of-showrunning-mean-version
Deck Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
18
The slide uses a provocative, informal tone to emphasize the professional necessity of timely script delivery.11 laws of showrunning mean version · 11-laws-of-showrunning-mean-version
Deck Investor relations Beat · Satisfaction1 hit
21
The slide uses a humorous anecdote about Herbert Von Karajan to illustrate the trap of trying to be everywhere at once.11 laws of showrunning mean version · 11-laws-of-showrunning-mean-version
Deck Investor relations Beat · Action1 hit
25
This appears to be a page from a manuscript or a narrative-heavy presentation deck.11 laws of showrunning mean version · 11-laws-of-showrunning-mean-version
Deck Investor relations Beat · Action1 hit
29
This slide outlines a specific management process for television production, emphasizing delegation and narrative focus.11 laws of showrunning mean version · 11-laws-of-showrunning-mean-version
Deck Investor relations Beat · Action1 hit